On Friday, ground was broken for the GoCo Health Innovation in the City of a 100.000-square-foot space, where it is planned to 350 businesses, researchers, and students in the biotechnology sector. The venture is an investment of 3.5 billion when it is fully developed within a period of five to eight years of age.
Ibrahim Baylan (S): , who was one of the guests at the ceremony that the government will continue its co-financing of astrazeneca’s so-called “ Bio-Venture the Hub, where companies large and small can work together and take advantage of the läkemedelsjättens resources.
By the innovation agency Vinnova, the government 20 million dollars. At the same time, the Western Region of ten million, and the Astra Zeneca 30 million, giving a total of € 60 million. The initiative, according to Ibrahim Baylan, in line with the new strategy for the life sciences, which the government launched.
“ Our goal is for Sweden to become one of the world’s leading countries in the field of life sciences. All of us understand that our great advantage is not going to be the domestic market. However, we are skilled at innovation, new products and services, and we’ll deal with it, it is required that we have the hooks of the arm, in this case, Astra Zeneca, “ says Baylan to the ROTOR.
He does not rule out that the government is going to introduce a similar co-operation efforts within a short time.
„this is the next step in the world of innovation,“ says minister of economic affairs,
in 2014, and we are now looking forward to developing co-operation with other stakeholders of the GoCo Health Innovation in the City.
Matti Ahlqvist, the company’s operating manager, pointing to the rapid pace of technological development and digitalization, which makes the co-operation between different sectors is essential.
“ No one knows enough to answer all of the questions. It is for this reason that we need to work together to find a solution, “ says Ahlqvist.
GoCo-Health Innovation in the City of Mölndal in western sweden, is intended to collect 350 companies, academic researchers, and students in the biotechnology sector. Photo by GoCo
the moves, the major is the japanese Fujirebio, which is part of the global group Miraca Group. The company Fujirebio Diagnostics is already established in Gothenburg, sweden. The agreement was signed at the Swedish embassy in Tokyo last week.
Peter Wahlgren, ceo of GoCo Development AB, which, together with the real estate company is the Next Step, Mölndal municipality, and astrazeneca, which is behind the initiative, is happy to have gotten the japanese on board.
“ It’s a great player, and it shows in the project, like, say, This.
once Fully developed is estimated to GoCo’s Health Innovation in the City to provide 7.000 jobs in the major with The president, Who Vramsten (M), noting that the planning process has gone by very quickly, bearing in mind that the idea was launched by 2017, and with pride.
„this is going to put Hershey on the map, not just in the united states, but in Europe,“ said Vramsten
find out more about Sweden here.
